Wolverine Trading, LLC Agenus Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$0.63 - $1.14 $441 - $797	-700 Reduced 2.45%	27,900 $23,000
Q3 2023 Nov 15, 2023	BUY	$1.12 - $1.88 $15,792 - $26,508	14,100 Added 97.24%	28,600 $32,000
Q2 2023 Aug 23, 2023	SELL	$1.31 - $2.04 $32,750 - $51,000	-25,000 Reduced 63.29%	14,500 $23,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $101,210 - $205,910	-69,800 Reduced 63.86%	39,500 $57,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $124,432 - $200,200	61,600 Added 129.14%	109,300 $262,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $15,288 - $24,492	-7,800 Reduced 14.05%	47,700 $98,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $15,990 - $32,472	12,300 Added 28.47%	55,500 $113,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $101,520 - $149,904	43,200 New	43,200 $113,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $720,656 - $1.42 Million	-246,800 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $1.23 Million - $1.64 Million	246,800 New	246,800 $1.29 Million
Q2 2021 Aug 06, 2021	SELL	$2.56 - $5.49 $103,936 - $222,894	-40,600 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$2.69 - $5.25 $45,461 - $88,725	16,900 Added 71.31%	40,600 $110,000
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $10,144 - $14,368	3,200 Added 15.61%	23,700 $78,000
Q3 2020 Nov 13, 2020	SELL	$2.98 - $5.2 $8,046 - $14,040	-2,700 Reduced 11.64%	20,500 $83,000
Q2 2020 Aug 13, 2020	SELL	$2.29 - $4.24 $5,725 - $10,600	-2,500 Reduced 9.73%	23,200 $92,000
Q1 2020 May 11, 2020	SELL	$1.92 - $4.39 $40,512 - $92,629	-21,100 Reduced 45.09%	25,700 $62,000
Q4 2019 Feb 12, 2020	BUY	$2.41 - $4.4 $32,053 - $58,520	13,300 Added 39.7%	46,800 $188,000
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $11,935 - $17,270	5,500 Added 19.64%	33,500 $89,000
Q2 2019 Aug 20, 2019	BUY	$2.53 - $3.04 $6,324 - $7,600	2,500 Added 9.8%	28,000 $84,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $36,897 - $54,831	-14,700 Reduced 36.57%	25,500 $76,000
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $25,440 - $42,560	16,000 Added 66.12%	40,200 $96,000
Q3 2018 Nov 14, 2018	SELL	$1.59 - $2.42 $43,407 - $66,066	-27,300 Reduced 53.01%	24,200 $52,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $70,551 - $121,404	20,100 Added 64.01%	51,500 $243,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $26,080 - $38,240	-8,000 Reduced 20.3%	31,400 $102,000
Q3 2017 Nov 15, 2017	BUY	$3.48 - $4.44 $137,112 - $174,936	39,400	39,400 $174,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account